Anaphylaxis
Dry powder epinephrine nasal spray outcomes meet, surpass autoinjector delivery
A dry powder epinephrine delivered via a nasal spray yielded drug exposures that were equal to or higher than those achieved through autoinjector in a canine model, according to the results of a study performed by Belhaven Biopharma.
Epinephrine nasal spray recommended for approval in European Union
An epinephrine nasal spray is closer to approval in Europe, according to a press release from ARS Pharmaceuticals.
Q&A: Testing for polyethylene glycol in drug allergies remains challenging
Hypersensitivity to polyethylene glycol may be rare, but when reactions to PEG in drugs do occur, they often are due to molecular weights of 3350 and higher, according to a study published in Annals of Allergy, Asthma & Immunology.
Top news of June: FAA guidelines, In-N-Out, microaggressions, more
Healio has compiled June’s most-read news in asthma and allergy.
Epinephrine nasal spray effective, tolerable with nasal congestion
Patients with nasal congestion experienced enhanced absorption of epinephrine when it was administered via nasal spray compared with intramuscular administration, according to a study published in Annals of Allergy, Asthma & Immunology.
Early introduction guidelines may reduce peanut anaphylaxis risks in children
The 2017 Addendum Guidelines for the Prevention of Peanut Allergy were associated with lower new-onset anaphylaxis rates in children, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.
Pediatric egg-induced anaphylaxis may present differing symptoms than other food allergies
Children experiencing egg-induced anaphylaxis may be seeing certain symptoms that differentiate them from other food-induced anaphylaxis, according to a study published in Annals of Allergy, Asthma and Immunology.
Top in allergy/asthma: Clause to update airplane medical kits; child food allergies common
H.R. 3935, a bill signed into law on May 16 by President Joe Biden, includes a clause stating that the Federal Aviation Administration must reconsider medications and protocol for emergency treatment of anaphylaxis on airplanes.